Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Theory Core
NYU College of Global Public Health - Professor
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Active
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Active
Principal Investigator, Risk Factors for AIDS among Drug Users: Getting Close to Zero. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed


Des Jarlais DC, Hammett TM, Kieu B, Chen Y, Feelemyer J (2018).
Working with persons who inject drugs and live in rural areas: Implications from China/Vietnam for the USA
Current HIV/AIDS Reports, 15 (4), 302-307. doi: 10.1007/s11904-018-0405-0.

Jogeda EL, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uuskula A, Toompere K, Lutsar I, Huik K (2018).
Association of IFNlambda4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs
Journal of Medical Virology [Epub 2018 Jul 10]. doi: 10.1002/jmv.25258.

Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR (2018).
Availability of HIV and HCV on-site testing and treatment at syringe service programs in the United States
Journal of Acquired Immune Deficiency Syndromes [Epub 2018 Jul 3]. doi: 10.1097/QAI.0000000000001792.

Tempalski B, Cooper HLF, Kelley ME, Linton SL, Wolfe ME, Chen YT, Ross Z, Des Jarlais DC, Friedman SR, Williams LD, Semaan S, DiNenno E, Wejnert C, Broz D, Paz-Bailey G (2018).
Identifying which place characteristics are associated with the odds of recent HIV testing in a large sample of people who inject drugs in 19 US metropolitan areas
AIDS and Behavior [Epub 2018 Jul 3]. doi: 10.1007/s10461-018-2217-z.

Duong HT, Des Jarlais D, Khuat OHT, Arasteh K, Feelemyer J, Khue PM, Giang HT, Laureillard D, Hai VV, Vallo R, Michel L, Moles JP, Nagot N (2018).
Risk behaviors for HIV and HCV infection among people who inject drugs in Hai Phong, Viet Nam, 2014
AIDS and Behavior, 22 (7), 2161-2171. doi: 10.1007/s10461-017-1814-6.

Selected Press